Leonurine Attenuates Neuroinflammation and Oxidative Stress in a Pentylenetetrazoleinduced Epilepsy in Rats

ABSTRACT

Background: Epilepsy is a complex neurological condition characterized by recurrent seizures due to abnormal neuronal activity. Objectives: The major aim of this study is to examine the therapeutic activities of leonurine in a pentylenetetrazole (PTZ)- challenged epileptic seizure model in rats. Materials and Methods: Epilepsy was initiated in the rats by administering 45 mg/kg of PTZ. Rats received pretreatment of leonurine (10 mg/kg) and the standard drug diazepam 30 min before the PTZ treatment. Seizure severity was evaluated in both the control and experimental rats. The levels of oxidative stress indicators, inflammatory cytokines, ion transports, and neurotransmitters were assessed utilizing the appropriate test kits. Molecular markers such as cytochrome-c (cyt-c), caspase-3, cyclooxygenase-2 (COX-2), toll-like receptor 4 (TLR-4), mammalian target of rapamycin (mTOR), and nuclear factor kappa B (NF-κB) concentrations were studied using respective kits. Histological studies were conducted on the brain tissues of the experimental rats. Results: Leonurine treatment significantly diminished seizure severity and increased locomotor activity in the epileptic rats. Leonurine treatment also effectively regulated neurotransmitters and ion transport mechanisms, reduced oxidative stress, decreased TLR-4 and high mobility group box 1 (HMGB1), decreased inflammatory cytokine, regulated protein kinase B (AKT)/mTOR axis, and diminished caspase-3, cyt-c, COX-2, and NF-κB concentrations in both cortex and hippocampal regions of the rats with epilepsy. The findings of histopathological studies also proved the therapeutic effects of leonurine. Conclusion: It may be concluded that leonurine offers a promising therapeutic candidate to treat epilepsy. Further studies are necessary to understand the underlying mechanisms of leonurine’s therapeutic benefits on epilepsy.

KEYWORDS

• Kindling
• nitric oxide
• neuroinflammation
• neurotransmitters
• leonurine
• pentylenetetrazole

Showing references and in-text citations exactly as published.

• DOI10.1177/09731296251322829Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 22, ISSUE 1A Comparative Study Between Cheilocostus speciosus (Sea Qust) and Saussurea lappa (Indian Qust): Decoding the Spectral, Anti-bacterial, and Anti-cancer AnalysesSiddig Ibrahim Abdelwahab, Manal Mohamed Elhassan Taha, Syam Mohan, Mukul Sharma, Md Shamsher Alam, Mohamed Eltaib Elmobark, Sivakumar S Moni, Mohammed Albeishy, Ohood Sufyani, Afraim Koty, Adel S. Al-Zubairi · pp. 125–135Original Research ArticleSame type: Article
• Article · VOLUME 22, ISSUE 1Integrate Molecular Docking and Animal Model Validation into the Research of the Effect and Potential Mechanism of Eupatilin Against Myocardial Ischemia/Reperfusion InjuryYulong Li, Xiang Li · pp. 136–146Original Research ArticleSame type: Article
• Article · VOLUME 22, ISSUE 1Albiflorin Enhances Diabetic Wound Healing Process by Enhancing Re-epithelialization and Ameliorating Inflammation and Oxidative Stress in Diabetic RatsJie Yang, Xinrong Zhang, Jiawei Zhang, Lu Yan · pp. 147–157Original Research ArticleSame type: Article
• Article · VOLUME 22, ISSUE 1An Investigation of the Protective Effects of Trifolirhizin against MPTP-induced Parkinson’s Disease in MiceXiaoli Yuan · pp. 158–166Original Research ArticleSame type: Article